SLC35A2 and cancer: Immunoblotting and functional assays with known endogenous (bilirubin, estradiol, arachidonic acid) and xenobiotic (anti-cancer agent SN-38 and the anti-viral agent zidovudine) substrates demonstrate the expression of catalytically active UGT enzymes (Figure 1C,D).